- 01A low result rules IBD out; a high result does not rule it in
In adults, fecal calprotectin picks up about 93 of every 100 IBD cases, so a result under about 50 µg/g makes IBD unlikely. A high result means the bowel is inflamed, and the cause could just as easily be infection, NSAIDs, polyps, cancer or diverticulitis as IBD.
In adults with gut symptoms, a fecal calprotectin under about 50 µg/g makes inflammatory bowel disease (IBD, the group that includes Crohn's disease and ulcerative colitis) unlikely. That low result is the most reliable thing the test can tell you, because in adults it picks up about 93 of every 100 IBD cases 2. Clinicians usually repeat a higher result before reading it as disease. In the York care pathway, used in parts of the NHS, any result of 100 µg/g or more is repeated. If the repeat is over 250 µg/g, the patient is sent urgently to a gastroenterologist (a gut specialist) 6. A high fecal calprotectin means the bowel wall is inflamed, and the cause of that inflammation still has to be found.
What fecal calprotectin measures
Calprotectin is a protein found mostly inside neutrophils, where it makes up roughly 60% of the soluble protein in the cell 3. Neutrophils are the first white blood cells to arrive at inflamed tissue. When they pour into an inflamed bowel wall, calprotectin is shed into the gut and leaves the body in stool. Calprotectin stays stable in stool for at least a week at room temperature. That means the amount a lab finds rises with the amount of neutrophil-driven inflammation in the gut 3.
How calprotectin travels from an inflamed bowel to the lab
Fecal lactoferrin is another neutrophil protein measured in stool, and it is read in a similar way. Its own page covers how the two compare in practice. For inflammation measured in blood, see CRP and inflammation markers explained.
Normal, borderline and high: the cutoffs
Where an example result of 120 µg/g fallsµg/g
| Result (µg/g) | How it is usually read | What usually happens next |
|---|---|---|
| Under 50 | Normal 1 | In adults with symptoms, IBD becomes unlikely. The clinician considers functional causes such as IBS. |
| 50 to 99 | Normal or borderline, depending on the lab | In the York pathway this is still managed as likely IBS. The patient is reviewed and referred if symptoms continue 6. |
| 100 to 250 | Borderline | Usually repeated about 2 to 4 weeks later. If the repeat stays in this band, the next step is a routine referral to a gastroenterologist 6. If you take NSAIDs, ask the prescriber whether to pause them first. |
| Over 250 (some labs use 200) | Raised | If a repeat test confirms it, an urgent referral follows, often straight to colonoscopy (a camera test of the whole large bowel) 6. |
| Over 150, in someone already diagnosed with ulcerative colitis | Monitoring cutoff from the American Gastroenterological Association (AGA), a separate use | Supports active disease when symptoms are moderate to severe 4. |
Fecal calprotectin has no separate 'optimal' target. The lab's upper limit of normal, usually 50 µg/g, works as the target, and a lower result has no extra meaning. Different test kits read the same stool slightly differently, so a value near a cutoff can be labeled normal at one lab and borderline at another. Reference ranges explained covers why labs differ.
Young children run higher
Healthy infants and children under about age 4 tend to have higher fecal calprotectin than adults. This helps explain the BMJ meta-analysis results. Calprotectin's specificity (how often people without IBD correctly get a normal result) was 0.76 in children and teenagers, compared with 0.96 in adults 2. In plain terms, more healthy children got a falsely raised result. A pediatrician reads a young child's result against age-adjusted expectations.
Why a low result is the one to trust
A 2010 BMJ meta-analysis (a study that combines the results of earlier studies) pooled 6 studies covering 670 adults with suspected IBD 2. Across those studies, fecal calprotectin had a sensitivity of 0.93 and a specificity of 0.96. Sensitivity of 0.93 means the test flagged 93 of every 100 adults who turned out to have IBD, so a normal result leaves little room for missed disease. Specificity of 0.96 means 96 of every 100 adults without IBD got a normal result. In 7 studies covering 371 children and teenagers, sensitivity was 0.92 and specificity was 0.76 2.
Testing for faecal calprotectin is a useful screening tool for identifying patients who are most likely to need endoscopy for suspected inflammatory bowel disease.van Rheenen PF, Van de Vijver E, Fidler V. BMJ 2010;341:c3369 2
The UK's National Institute for Health and Care Excellence (NICE) recommends fecal calprotectin to help clinicians tell IBD from IBS. The recommendation covers adults with recent-onset lower gut symptoms who are being considered for specialist assessment, as long as cancer is not suspected. It also covers children with suspected IBD who have been referred to a specialist 1. In the US, the American College of Gastroenterology recommends fecal calprotectin or fecal lactoferrin, plus CRP, to rule out IBD in people with suspected IBS and diarrhea who have no warning signs 8. IBS causes real symptoms but does not draw neutrophils into the bowel wall, so IBS on its own should not raise calprotectin. A normal result in someone with typical IBS symptoms supports the IBS diagnosis. Sometimes calprotectin is normal but symptoms such as chronic diarrhea or greasy stools continue. Other stool tests, such as fecal elastase-1, can then check for other causes. The gut hub covers the rest.
What else raises calprotectin
Fecal calprotectin rises with neutrophil-driven inflammation anywhere in the gut, and IBD is only one cause. Bjarnason's review notes that almost every disease of the colon, and many diseases of the small bowel, come with inflammation 3. Before a high result is read as Crohn's disease or ulcerative colitis, the clinician has to rule out the other causes in the table.
| Cause | Why it raises calprotectin |
|---|---|
| Gut infection (bacterial or viral gastroenteritis) | Infection draws neutrophils into the lining until it clears. Some food infections give very high readings 3. |
| Regular NSAID use (ibuprofen, naproxen, aspirin) and alcohol | Both can cause low-grade inflammation of the bowel lining 3. |
| Colorectal cancer and large polyps | These can raise calprotectin, but a normal result does not fully rule them out 7. |
| Diverticulitis | Inflamed pouches in the colon wall attract neutrophils. |
| Microscopic colitis | Inflammation that is visible only under a microscope can still raise calprotectin. |
Calprotectin, FIT, CRP and lactoferrin
Calprotectin finds inflammation and FIT finds blood, so a normal calprotectin does not rule out bowel cancer. NICE limits calprotectin to people in whom cancer is not suspected 15.
| Fecal calprotectin | FIT (fecal immunochemical test) | CRP (C-reactive protein) | Fecal lactoferrin | |
|---|---|---|---|---|
| What it measures | Neutrophil protein in stool | Human blood in stool | Liver-made inflammation protein in blood | Another neutrophil protein in stool |
| Sample | Stool | Stool | Blood | Stool |
| Where it is most useful | Telling IBD from IBS; monitoring known IBD | Bowel cancer screening and triage | Body-wide inflammation | Gut inflammation; similar job to calprotectin |
| Main blind spot | Cannot name the cause; can miss cancer | Cannot measure inflammation | Can be normal in active IBD, especially ulcerative colitis | Less widely used and studied |
| Own page | This page | FIT | CRP | Lactoferrin |
- Blood in your stool or bleeding from the bottom
- Diarrhea that wakes you at night to pass stool
- Weight loss you cannot explain
- Fever
- Anemia, meaning low hemoglobin or low ferritin
- A lasting change in your bowel habit, especially if you are over 45
- A lump in your belly or back passage
- A family history of bowel cancer or IBD
For more on low blood counts and iron, see anemia and iron deficiency. Microbiome panels often include stool markers such as zonulin and secretory IgA. Neither has the guideline backing that fecal calprotectin has.
If you already have ulcerative colitis
The American Gastroenterological Association (AGA) uses a fecal calprotectin cutoff of 150 µg/g for people already diagnosed with ulcerative colitis. In someone whose symptoms are in remission, a result below 150 µg/g helps rule out active inflammation. In someone with moderate to severe symptoms, a result above 150 µg/g supports active disease without routine endoscopy 4. The 150 µg/g cutoff is for monitoring known disease. It does not replace the bands used when IBD is first suspected.
How the test works in practice
- No fasting is needed. You collect a small stool sample at home with the scoop and pot the lab provides, then return it as instructed. Some labs ask for the first stool of the day.
- Fecal calprotectin is a separate stool order. It is not part of routine blood work or a standard stool culture.
- Results usually come back within a few days. In the US, insurance often covers the test when a clinician orders it for symptoms, but coverage and cash prices vary, so ask the lab or your plan.
- Fecal calprotectin is not a screening test for people without symptoms, and relatives are not routinely tested. A family history of bowel cancer usually means colonoscopy, often starting earlier than average. Ask your clinician when to begin (see bowel cancer screening).
- Repeat timing depends on the reason for the test. A borderline result is usually repeated within a few weeks; in the York pathway the typical repeat came 18 days after the first 6. People with known IBD are retested on a schedule set by their specialist.
For more on stool and blood markers of gut health, see the gut hub, the inflammation hub and how to read any lab result.
Link · NICEFaecal calprotectin diagnostic tests for inflammatory diseases of the bowel (DG11)The UK guidance on using calprotectin to separate IBD from IBS in adults and children.nice.org.uk
Citations
- NICE Diagnostics Guidance DG11: Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel (2013)
- van Rheenen PF, Van de Vijver E, Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ 2010;341:c3369
- Bjarnason I. The use of fecal calprotectin in inflammatory bowel disease. Gastroenterology & Hepatology 2017;13(1):53-56
- Singh S, Ananthakrishnan AN, Nguyen NH, et al. AGA Clinical Practice Guideline on the role of biomarkers for the management of ulcerative colitis. Gastroenterology 2023;164(3):344-372
- NICE Guideline NG12: Suspected cancer: recognition and referral (2015)
- Turvill J, Turnock D, Holmes H, et al. Evaluation of the clinical and cost-effectiveness of the York Faecal Calprotectin Care Pathway. Frontline Gastroenterology 2018;9(4):285-294
- Turvill J, Aghahoseini A, Sivarajasingham N, et al. Faecal calprotectin in patients with suspected colorectal cancer: a diagnostic accuracy study. British Journal of General Practice 2016;66(648):e499-e506
- Lacy BE, Pimentel M, Brenner DM, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. American Journal of Gastroenterology 2021;116(1):17-44
Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.